scispace - formally typeset
C

Clay F. Semenkovich

Researcher at Washington University in St. Louis

Publications -  200
Citations -  33711

Clay F. Semenkovich is an academic researcher from Washington University in St. Louis. The author has contributed to research in topics: Insulin resistance & Fatty acid synthase. The author has an hindex of 70, co-authored 193 publications receiving 30175 citations. Previous affiliations of Clay F. Semenkovich include Rush University Medical Center & Baylor College of Medicine.

Papers
More filters
Journal ArticleDOI

The importance of context to the genetic architecture of diabetes-related traits is revealed in a genome-wide scan of a LG/J × SM/J murine model

TL;DR: The data demonstrate that the effects of genes on complex trait variation are highly context-dependent and that the same genomic sequence can affect traits differently depending on an individual’s sex and/or dietary environment.
Journal ArticleDOI

α2β1 Integrin and Development of Atherosclerosis in a Mouse Model. Assessment of Risk

TL;DR: The results suggest that risk for arterial thrombotic disease associated with high-level &agr;2&bgr;1 integrin expression is not attributable to enhanced development of atherosclerosis per se but may rather be a consequence of thromBotic complications at the plaques.
Journal ArticleDOI

Requirement for p38 Mitogen-Activated Protein Kinase Activity in Neointima Formation After Vascular Injury

TL;DR: SMC p38α MAPK activation is required for neointima formation, perhaps because of its ability to promote retinoblastoma protein phosphorylation and minichromosome maintenance protein 6 expression.
Journal ArticleDOI

Alterations in thigh subcutaneous adipose tissue gene expression in protease inhibitor-based highly active antiretroviral therapy.

TL;DR: In the PI group, the messenger RNA expression levels of the CCAAT/enhancer-binding protein alpha, leptin, and adiponectin were significantly lower than the levels measured in the PI-naive group.
Journal ArticleDOI

Absence of Peroxisome Proliferator-Activated Receptor-α Abolishes Hypertension and Attenuates Atherosclerosis in the Tsukuba Hypertensive Mouse

TL;DR: The possibility that peroxisome proliferator-activated receptor-&agr; activation may aggravate hypertension and hasten atherosclerosis in the context of an activated renin-angiotensin system is raised.